| row-start col-xs-12 |
Conference Organisation
The Annual Meeting of the Association for Radiation Research 2020 is organised on behalf of ARR by Professor Susan Short.
Professor Short is a clinical oncologist with a specialist research interest in treating adults with primary brain tumours. She trained at King’s College London and took up a post as Senior Lecturer at University College London in 2004, where she ran a translational research group as CRUK Clinician Scientist and Senior Fellow. She moved to Leeds in 2012 as professor of Clinical Oncology and Neuro-Oncology and currently leads the brain cancer research section at Leeds Institute of Cancer and Pathology.
Professor Short’s major research interests are in the optimisation of radiotherapy for patients with gliomas, particularly through improved understanding of mechanisms of radioresistance in stem cell populations. Her current work is funded through MRC, CRUK, The Brain Tumour Charity, BTRS and PPR Foundation and also includes projects investigating the use of micro-RNAs as biomarkers and targets and investigation of novel and re-purposed drugs as cytotoxics in glioma.
Professor Short has major collaborations with other Group leaders in LICAP with joint projects in glioma tumour vasculature and migration (Mavria), stem cell biology (Wurdak ), glioma genomics (Stead) and immunology (Cook). Significant external collaborations include researchers at The Institute of Cancer Research (Melcher), University of Glasgow (Chalmers), Brigham Women’s Hospital and The University of Harvard (Lawler) and The University of Hamburg (Kriegs) amongst others.
She is a member of the EU INSERT consortium investigating novel imaging techniques applied to glioma patients. Prof Short runs a portfolio of clinical studies for patients with brain tumours including early phase studies investigating the use of oncolytic viruses as immune adjuvants and the activity of inhibitors of DNA repair and autophagy as radiation and chemotherapy sensitisers.
Professor Short’s major research interests are in the optimisation of radiotherapy for patients with gliomas, particularly through improved understanding of mechanisms of radioresistance in stem cell populations. Her current work is funded through MRC, CRUK, The Brain Tumour Charity, BTRS and PPR Foundation and also includes projects investigating the use of micro-RNAs as biomarkers and targets and investigation of novel and re-purposed drugs as cytotoxics in glioma.
Professor Short has major collaborations with other Group leaders in LICAP with joint projects in glioma tumour vasculature and migration (Mavria), stem cell biology (Wurdak ), glioma genomics (Stead) and immunology (Cook). Significant external collaborations include researchers at The Institute of Cancer Research (Melcher), University of Glasgow (Chalmers), Brigham Women’s Hospital and The University of Harvard (Lawler) and The University of Hamburg (Kriegs) amongst others.
She is a member of the EU INSERT consortium investigating novel imaging techniques applied to glioma patients. Prof Short runs a portfolio of clinical studies for patients with brain tumours including early phase studies investigating the use of oncolytic viruses as immune adjuvants and the activity of inhibitors of DNA repair and autophagy as radiation and chemotherapy sensitisers.
Administrative Support
Conference Management and administrative support is provided by MeetinLeeds. Please direct all queries to arr2020@leeds.ac.uk
